Literature DB >> 20717929

Regulation of UDP-glucose dehydrogenase is sufficient to modulate hyaluronan production and release, control sulfated GAG synthesis, and promote chondrogenesis.

Claire E Clarkin1, Steve Allen, Nikki J Kuiper, Benjamin T Wheeler, Caroline P Wheeler-Jones, Andrew A Pitsillides.   

Abstract

Glycosaminoglycans (GAGs) are critical for extracellular matrix (ECM) integrity in cartilage but mechanisms regulating their synthesis are not defined. UDP-glucose dehydrogenase (UGDH) catalyses UDP-glucose oxidation to UDP-glucuronic acid, an essential monosaccharide in many GAGs. Our previous studies in articular surface (AS) cells from embryonic joints have established pivotal roles for mitogen-activated protein kinases (MAPK) in synthesis of the unsulfated GAG, hyaluronan (HA). We investigated the functional significance of UGDH in GAG production and chondrogenesis, and determined roles for MEK-ERK and p38MAPK pathways in regulating UGDH expression and function. Inhibitors of MEK and p38MAPK reduced UGDH protein in AS cells. Treatment with TGF-β (archetypal growth factor) increased UGDH expression, sulfated (s)-GAG/HA release and pericellular matrix formation in a p38MAPK-dependent manner. Retroviral overexpression of UGDH augmented HA/sGAG release and pericellular matrix elaboration, which were blocked by inhibiting MEK but not p38MAPK. UGDH overexpression increased cartilage nodule size in bone marrow culture, promoted chondrogenesis in limb bud micromass culture and selectively suppressed medium HA levels and modified GAG sulfation, as assessed by FACE analysis. Our data provide evidence that: (i) TGF-β regulates UGDH expression via p38MAPK to modulate sGAG/HA secretion, (ii) MEK-ERK, but not p38MAPK facilitates UGDH-induced HA and sGAG release, and (iii) increased UGDH expression promotes chondrogenesis directly and differential modifies GAG levels and sulfation. These results indicate a more diverse role for UGDH in the support of selective GAG production than previously described. Factors regulating UGDH may provide novel candidates for restoring ECM integrity in degenerative cartilage diseases, such as osteoarthritis.Arthritis Research Campaign.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20717929     DOI: 10.1002/jcp.22393

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

1.  Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.

Authors:  Ronan S Rogers; Moyez Dharsee; Suzanne Ackloo; Jeremy M Sivak; John G Flanagan
Journal:  Mol Cell Proteomics       Date:  2011-11-29       Impact factor: 5.911

2.  Integrative Metabolic Pathway Analysis Reveals Novel Therapeutic Targets in Osteoarthritis.

Authors:  Beatriz Rocha; Berta Cillero-Pastor; Gert Eijkel; Valentina Calamia; Patricia Fernandez-Puente; Martin R L Paine; Cristina Ruiz-Romero; Ron M A Heeren; Francisco J Blanco
Journal:  Mol Cell Proteomics       Date:  2020-01-24       Impact factor: 5.911

3.  The UDP-glucose dehydrogenase of Escherichia coli K-12 displays substrate inhibition by NAD that is relieved by nucleotide triphosphates.

Authors:  Iain L Mainprize; Jordan D Bean; Catrien Bouwman; Matthew S Kimber; Chris Whitfield
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

4.  CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention.

Authors:  Yi Huang; Emily B Askew; Cheryl B Knudson; Warren Knudson
Journal:  Matrix Biol       Date:  2016-04-14       Impact factor: 11.583

5.  A genome-wide association study of osteochondritis dissecans in the Thoroughbred.

Authors:  Laura J Corbin; Sarah C Blott; June E Swinburne; Charlene Sibbons; Laura Y Fox-Clipsham; Maud Helwegen; Tim D H Parkin; J Richard Newton; Lawrence R Bramlage; C Wayne McIlwraith; Stephen C Bishop; John A Woolliams; Mark Vaudin
Journal:  Mamm Genome       Date:  2011-11-04       Impact factor: 2.957

Review 6.  Cartilage biology in osteoarthritis--lessons from developmental biology.

Authors:  Andrew A Pitsillides; Frank Beier
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

7.  Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenase.

Authors:  C E Clarkin; S Allen; C P Wheeler-Jones; E R Bastow; A A Pitsillides
Journal:  Matrix Biol       Date:  2011-02-01       Impact factor: 11.583

8.  Structural and kinetic evidence that catalytic reaction of human UDP-glucose 6-dehydrogenase involves covalent thiohemiacetal and thioester enzyme intermediates.

Authors:  Sigrid Egger; Apirat Chaikuad; Mario Klimacek; Kathryn L Kavanagh; Udo Oppermann; Bernd Nidetzky
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

Review 9.  Integration of Sugar Metabolism and Proteoglycan Synthesis by UDP-glucose Dehydrogenase.

Authors:  Brenna M Zimmer; Joseph J Barycki; Melanie A Simpson
Journal:  J Histochem Cytochem       Date:  2020-08-04       Impact factor: 2.479

10.  Krüppel-like factor 2 is required for normal mouse cardiac development.

Authors:  Aditi R Chiplunkar; Tina K Lung; Yousef Alhashem; Benjamin A Koppenhaver; Fadi N Salloum; Rakesh C Kukreja; Jack L Haar; Joyce A Lloyd
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.